Multidrug Resistance Mutation (MDR1/ABCB1) in Dogs
Multidrug Resistance Mutation (MDR1/ABCB1) is a high-severity neurological condition that can affect dogs of all ages and breeds. The MDR1 (ABCB1) mutation causes a defective P-glycoprotein pump in the blood-brain barrier, allowing normally safe drugs (ivermectin, loperamide, certain chemotherapy agents) to accumulate in the brain to toxic levels. Affected dogs can die from routine doses. It is documented across 6 breeds, though prevalence and severity can differ significantly between them. It typically becomes apparent at Any age (drug-triggered). Early signs to watch for include neurological signs after drug exposure, tremors, ataxia, and seizures, blindness, and coma. When treatment is required, costs are estimated at £500-£3,000 per event depending on severity, location, and the specific intervention needed. Multidrug Resistance Mutation (MDR1/ABCB1) has a hereditary component, so health-screening certificates from the breeder are strongly recommended for predisposed breeds. This page covers symptoms, treatment options, and preventive steps — along with breed-specific information where available.
Signs & Symptoms
The following symptoms are commonly associated with Multidrug Resistance Mutation (MDR1/ABCB1) in dogs. If your dog displays several of these signs, consult your vet promptly — early diagnosis typically leads to better outcomes.
- Neurological signs after drug exposure
- Tremors, ataxia, and seizures
- Blindness
- Coma
- Death in severe cases
Treatment Overview
No treatment for the mutation itself. Management involves identifying mutation status via DNA test and avoiding all MDR1-sensitive drugs. If intoxication occurs, supportive care and lipid emulsion therapy may help.
Typical onset: Any age (drug-triggered)
Prevention & Screening
While not all cases of Multidrug Resistance Mutation (MDR1/ABCB1) can be prevented, the following steps reduce risk or enable earlier intervention:
- DNA test all herding breeds before drug administration
- Never use ivermectin at anti-parasitic doses in untested herding breeds
- Alert veterinarian to mutation status
Estimated Treatment Cost
Treatment for Multidrug Resistance Mutation (MDR1/ABCB1) is estimated at £500-£3,000 per event, depending on severity, the specific intervention required, and your location. Costs may be higher for surgical procedures or ongoing management. Comprehensive pet insurance covering hereditary conditions is strongly recommended.
Breeds Affected by Multidrug Resistance Mutation (MDR1/ABCB1)
The following 5 breeds are documented as being susceptible to Multidrug Resistance Mutation (MDR1/ABCB1). Click any breed to view breed-specific information about this condition, including prevalence and recommended screening.
Looking for more information? Browse all dog health conditions or explore the health guides for in-depth breed care advice.